Athenex’s bid to offer an oral version of an intravenous chemotherapy has stalled after the FDA rejected the drug. Among the remedies proposed by the regulator is another Phase 3 study.
Rep. Christopher Collins of New York had suspended his campaign after his indictment on insider trading charges related to Australia-based Innate Immunotherapeutics.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Do EHRs make healthcare more or less safe? Do physicians spend too much time on EHRs? These are a few of the questions that HEALTHeLink asked 1,000 consumers in Western New York as part of a new survey.
One thing is clear: if you receive a letter and see HIPAA spelled “HIPPA,” you’d be wise to give it a second glance.
Buffalo diagnostics company Empire Genomics is readying itself to acquire new technologies, grow its staff and increase its test offerings. It plans to do so with $1 million in recent financing from Rand Capital and Buffalo-area incubator Z80 Labs. Empire Genomics was launched in 2006 at the Roswell Cancer Institute in Buffalo, New York. The lab develops high throughput […]
A mistake made by a PhD student in a University of Montana lab nearly a decade ago is now on the brink of mid-stage clinical trials as a potential treatment for traumatic brain injury. And, most surprising of all, the treatment consists of a small dose of methamphetamine. It all started when a research assistant […]
The NYTimes points toward areas of the United States where surgeries may be much cheaper for some patients, in part due to programs trying to drive down costs, in a comment-driven follow-up to the newspaper’s article on medical tourism and the medical device industry. The California Public Employees’ Retirement System (CalPERS) program is the exemplar […]
